High-frequency terms such as “gut microbiota,” “tumor microenvironment,” “aryl hydrocarbon receptor,” and “cancer immunotherapy” suggest a paradigmatic shift from single-pathway metabolic studies toward integrated perspectives that encompass metabolic–immune–microbial interactions. Here, AHR is linked to neoplasm.